BioLargo, Inc. · OTC:BLGO
BioLargo — Investor Presentation (October 2023)
18 slides from BioLargo's investor presentation, Oct 4, 2023
Slide 1: BioLargo: Cleantech Powerhouse
p Biolargo Cleantech Powerhouse Air - Water - Earth Strategy: Invent, Prove, Partner
Slide 2: Safe Harbor Statement
Safe Harbor Statement The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, the
Slide 3: Who we are
Who we are > Innovators, > Passionate about > Driven by a scientists, sustainability and mission to make engineers, and human health life better entrepreneurs
Slide 4: What we do
What we do > Best-in-class > Engineering- > Focus on solutions for forward problems without cleantech problems technologies solutions
Slide 5: The BioLargo Innovation Engine
The BioLargo Innovation Engine /, BioLargo We Make life Better \GBIOLICgO — snrecing Opioterge Water — pep BioLargo, Inc.is the parent company and primary financier and strategist. BioLargo Engineering, Science & Technologies, Inc. ex cts for third party ‘customers, integrates projects involving our
Slide 6: Revenue (5+ years)
REVENUE (5 3% YEARS) $ MILLIONS g 2018 2019 2020 2021 Trends are not necessarily indicative of future performance > 2022 Through Q2: 88% of lastyear's revenue Q3 expected to continue growth trajectory and assures record annual revenue for 2023 2023 (FIRST THREE QUARTERS ONLY) (GBiolacgo
Slide 7: Revenue and SG&A
REVENUE AND SG&A e Revenue 2+SG&A $40 $3.0 $20 $ MILLIONS ai a2 Q3 a4 ai az a3 ae a a2 a3 2021 2022 2023 Trends are not necessarily indicative of future performance *SG&A numbers not available until audt/review complete
Slide 8: Revenue and Net Cash Used in Operating Activities
REVENUE AND NET CASH USED IN OPERATING ACTIVITIES “tRevenue -Net cash used/generated in operating activities $ MILLIONS a a2 a3 as ai a2 a3 a4 a a2 a3 -$20 Trends are not necessarily indicative of future performance *SG&A numbers not available until audt/review complete
Slide 9: Net Stockholder's Equity (5+ years)
NET STOCKHOLDER'S EQUITY (5+ YEARS) $50 $40 2018 2019 a 2oat 2022 12023 a2-2023, 0 $20 $30 Trends are not necessarly indicative of future performance * Q3 estimatesnot available (20.0
Slide 10: POOPH - Consumer pet odor product
POOPH - Consumer pet odor product Product marketed and sold by our partners, award-winning consumer product experts (Ikigai Marketing Works) ONM receives manufacturer's margin and a royalty on sales Business strategy: ramp up sales and sell to a major consumer products company + ONM would receive 20
Slide 11: Pooph - Looking Forward
Pooph - Looking Forward Pooph management tells us: + Pooph team targets plan to secure national retailers that combined total 20,000+ stores under contract by end of 2023* * Plus: Pooph will continue to sell through DTC, Walmart, and Amazon * They anticipate =10X increase from today “logistics effor
Slide 12: ‘AEC Sacc © en
i ‘ ‘AEC Sacc © en y > Le = 6 BioLargo *Data available upon request for any claims, under NDA a
Slide 13: Mobile AEC Units Available for Lease, Sale, or Demonstration Now
Mobile AEC Units Available for Lease, Sale, or Demonstration Now
Slide 14: AEC awareness and marketing
AEC awareness and marketing
Slide 15: Selected by small New Jersey municipality for PFAS project
Selected by small New Jersey municipality as technology for PFAS project out to bid now (Biota | ts
Slide 16: Reasons to be Confident in BioLargo
’ * Revenue growth ’ * Good cash position 7 * SG&A not rising significantly with rising revenues * Analyst consensus: undervalued + Net operating income for ONM expected to continue increasing and capable of driving to profitability company-wide * PFAS tech has potential to drive long-term revenue *
Slide 17: Analyst Coverage
Analyst Coverage Michael Mathison ~ Singular Research * Initiated coverage in 2022 + 818-222-6234 + research@singularresearch.com = Oak Ridge Financi + Initiated coverage on Sept 12, 2023 OAK R DGE fy + ryanialceeana etn FINANCIAL *Contactthe analysts directly or BioLargo at Alex@biolarg0.com for co
Slide 18: The BioLargo Family of Companies
The BioLargo (s BioLargo Family of Companies “neous